Tolerance by Engaging Antigen During Cellular Homeostasis

NCT03504241 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

NIH

Sponsor class

Conditions

Kidney Transplantation
Renal Transplantation
Renal Transplant Recipient

Interventions

BIOLOGICAL: Donor-derived Mesenchymal Stromal Cells
DRUG: alemtuzumab
DRUG: belatacept
DRUG: sirolimus
DRUG: mycophenolate mofetil
DRUG: mycophenolate acid
DRUG: prednisone

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]
[object Object]